Skip to main content

Cytokine gene therapy of allergic airways inflammation

  • Chapter
Gene Therapy in Inflammatory Diseases

Part of the book series: Progress in Inflammation Research ((PIR))

  • 83 Accesses

Abstract

Although the chain of events leading to asthma is highly complex, the dysregulated production of type 2 cytokines, notably IL-4 and IL-5, by allergen-specific T cells, has emerged as an important causative factor [1, 2]. The symptoms of allergic asthma, including reversible airways occlusion and airways hyperreactivity (AHR), correlate with a local infiltration of the airways mucosa by inflammatory cells, whose recruitment and activation is influenced by IL-3, IL-4, IL-5, granulocyte-macrophage colony stimulating factor and other chemotactic agents produced by activated Th2 cells [3-6]. Indeed, the severity of disease appears to correlate with the degree of airways inflammation and the level of local Th2 cell activity [7, 8]. The molecular and cellular mechanisms underlying the presence of large numbers of Th2 cells in allergic airways remain to be resolved, however their products appear to have profound and specific effects in promoting allergic disease. IL-5, for example, regulates all stages of the development of eosinophils, which are consistently the predominant leukocyte population in the inflammatory infiltrate of asthmatics [5]. IL-4 modulates mast cell activity [4] and, through its influence on Ig class switching, regulates the production of IgE [3] which may specifically sensitize inflammatory cells implicated in allergic airways disease, including mast cells, eosinophils, basophils and macrophages. This leads to the release of inflammatory substances including histamine, leukotrienes, platelet-activating factor, cationic proteins and chemokines which may, in turn, augment the inflammatory process.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q (1995) Dys-regulation of interleukin 4, interleukin 5 and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 181: 33–40

    Article  PubMed  CAS  Google Scholar 

  2. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. New Eng J Med 326: 298–304

    Article  PubMed  CAS  Google Scholar 

  3. Geha RS (1992) Regulation of IgE synthesis in humans. J Allergy Clin Immunol 90: 143–1

    Article  PubMed  CAS  Google Scholar 

  4. Madden KB, Urban JF Jr, Ziltener HJ, Schrader JW, Finkelman FD, Katona IM (1991) Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol 147: 1387–1391

    PubMed  CAS  Google Scholar 

  5. Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79: 3101–3109

    PubMed  CAS  Google Scholar 

  6. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD (1996)Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 2: 449–456

    Article  PubMed  CAS  Google Scholar 

  7. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, Kay AB (1990) Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 142: 1407–1413

    PubMed  CAS  Google Scholar 

  8. Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, Jeffery PK, Durham SR, Kay AB (1992) Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 89: 821–829

    Article  PubMed  CAS  Google Scholar 

  9. Kung TT, Stelts DM, Zurcher JA, Adams GK, Egan RW, Kreutner W, Watnick AS, Jones H, Chapman RW (1995) Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 13: 360–365

    PubMed  CAS  Google Scholar 

  10. Nakajima H, Iwamoto I, Tomoe S, Matsumura R, Tomioka H, Takatsu K, Yoshida S (1992) CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 146: 374–377

    PubMed  CAS  Google Scholar 

  11. Brusselle GG, Kips JC, Tavernier JH, Van der Heyden JG, Cuvelier CA, Pauwels RA, Bluethmann H (1994) Attenuation of allergic airway inflammation in IL-4 deficient mice.Clin Exp Allergy 24: 73–80

    Article  PubMed  CAS  Google Scholar 

  12. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RC (1996) Interleukin 4, but not interleukin 5 or eosinophils, is required in an acute model of airway hyperrreactivity. J Exp Med 183: 109–117

    Article  PubMed  CAS  Google Scholar 

  13. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.J Exp Med 183: 195–2

    Article  PubMed  CAS  Google Scholar 

  14. Snapper CM, Paul WE (1987) Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944–947

    Article  PubMed  CAS  Google Scholar 

  15. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lym-phokinesecretion lead to different functional properties. Ann Rev Immunol 7: 145–173

    Article  CAS  Google Scholar 

  16. Yssel H, Schneider P, Spits H (1993) Production of IL-4 by human T cells and regulation of differentiation of T-cell subsets by IL-4. Res Immunol 144: 610–616

    Article  PubMed  CAS  Google Scholar 

  17. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993)Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199–1204

    Article  PubMed  CAS  Google Scholar 

  18. Seder RA, Gazzinelli R, Sher A, Paul WE (1993) Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 90: 10188–10192

    Article  PubMed  CAS  Google Scholar 

  19. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547–549

    Article  PubMed  CAS  Google Scholar 

  20. Trinchieri G (1995)Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol 13: 251–276

    Article  CAS  Google Scholar 

  21. Alfonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235–237

    Article  Google Scholar 

  22. Miller MA, Skeen MJ, Ziegler HK (1995) Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J Immunol 155: 4817–4828

    PubMed  CAS  Google Scholar 

  23. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, Sher A (1995An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376: 594–596

    Article  PubMed  CAS  Google Scholar 

  24. Wynn TA, Reynolds A, James S, Cheever AW, Caspar P, Hieny S, Jankovic D, Strand M, Sher A (1996) IL-12 enhances vaccine-induced immunity to Schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol 157: 4068–4078

    PubMed  CAS  Google Scholar 

  25. Oswald IP, Caspar P, Jankovic D, Wynn TA, Pearce EJ, Sher A (1994) IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J Immunol 153: 1707–1

    PubMed  CAS  Google Scholar 

  26. Wang ZE, Zheng S, Corry DB, Dalton DK, Seder RA, Reiner SL, Locksley RM (1994) Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci USA 91: 12932–12936

    Article  PubMed  CAS  Google Scholar 

  27. Marshall JD, Secrist H, DeKruyff RH, Wolf SF, Umetsu DT (1995) IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 155: 111–117

    PubMed  CAS  Google Scholar 

  28. Gavett SH, O’Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M (1995) Inter-leukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182: 1527–1536

    Article  PubMed  CAS  Google Scholar 

  29. Kips JC, Brusselle GJ, Joos GF, Peleman RA, Tavernier JH, Devos RR, Pauwels RA (1996) Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am Rev Respir Crit Care Med 153: 535–539

    CAS  Google Scholar 

  30. Sur S, Lam J, Bouchard P, Sigounas A, Holbert D, Metzger WJ (1996) Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 157: 4173–4180

    PubMed  CAS  Google Scholar 

  31. Mulligan RC (1993) The basic science of gene therapy. Science 260: 926–932

    Article  PubMed  CAS  Google Scholar 

  32. Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS, Ramshaw IA (1996) Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol 70: 7103–7

    PubMed  CAS  Google Scholar 

  33. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264: 561–

    Article  PubMed  CAS  Google Scholar 

  34. Ramshaw IA, Ramsay AJ, Karupiah G, Rolph MS, Mahalingam S, Ruby JC (1997) Cytokines and immunity to viral infection. Immunol Rev 159: 119–135

    Article  PubMed  CAS  Google Scholar 

  35. Coupar BEH, Andrew ME, Boyle DB (1988) A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene 68: 1–10

    Article  PubMed  CAS  Google Scholar 

  36. Sambrook J, Fritsch EF, Maniatis T (eds) (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press.

    Google Scholar 

  37. Andrew ME, Coupar BEH, Ada GL, Boyle DB (1986) Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microb Pathog 1: 443–452

    Article  PubMed  CAS  Google Scholar 

  38. Lack G, Bradley KL, Hamelmann E, Renz H, Loader J, Leung DYM, Larsen G, Gelfand EW (1996) Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol 157: 1432–1439

    PubMed  CAS  Google Scholar 

  39. Nakajima H, Iwamoto I, Yoshida S (1993) Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 148: 1102–1104

    Article  PubMed  CAS  Google Scholar 

  40. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamigo R, Vilcek J, Zinkernagel R, Aguet M (1993) Immune response in mice that lack the interferon-γ receptor. Science 259: 1742–1745

    Article  PubMed  CAS  Google Scholar 

  41. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ (1990) Regulatory effects of cytokines on eosinophil degranulation. J Immunol 144: 642–646

    PubMed  CAS  Google Scholar 

  42. Coleman JW, Morris AG (1991) Identification of a spleen cell-derived factor that inhibits sensitization of murine peritoneal mast cells as interferon-γ. Int Arch Allergy Appl Immunol 94: 179–180

    Article  PubMed  CAS  Google Scholar 

  43. Gauchat JF, Lebman DA, Coffman RL, Gascan H, De Vries J (1990) Structure and expression of germline e transcripts induced by interleukin-4 to switch to IgE production. J Exp Med 172: 463–473

    Article  PubMed  CAS  Google Scholar 

  44. Li X-M, Chopra RK, Chou T-Y, Schofield BH, Wills-Karp M, Huang S-K (1996) Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice. J Immunol 157: 3216–3219

    PubMed  CAS  Google Scholar 

  45. Drazen JM, Arm JP, Austen KF (1996) Sorting out the cytokines of asthma. J Exp Med 183: 1–5

    Article  PubMed  CAS  Google Scholar 

  46. Ramsay AJ, Leong KH, Ramshaw IA (1997) DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunisation with DNA and viral vectors. Immunol Cell Biol 75: 382–388

    Article  PubMed  CAS  Google Scholar 

  47. Shaheen SO, Aaby P, Hall AJ, Barker D, Heyes C, Shiell AW, Goudiaby A (1996) Measles and atopy in Guinea-Bisau. Lancet 347: 1792–1796

    Article  PubMed  CAS  Google Scholar 

  48. Shirakawa T, Enomoto T, Shimazu S, Hopkin J (1997) The inverse association between tuberculin responses and atopic disorder. Science 275: 77–79

    Article  PubMed  CAS  Google Scholar 

  49. Bochner BS, Undem BJ, Lichtenstein LM (1994) Immunological aspects of allergic asthma. Ann Rev Immunol 12: 295–335

    Article  CAS  Google Scholar 

  50. Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N (1993) Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 92: 404–411

    Article  PubMed  CAS  Google Scholar 

  51. Lacour M (1994) Acute infections in atopic dermatitis: a clue for a pathogenic role of a Th1/Th2 imbalance. Dermatology 188: 255–257

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Basel AG

About this chapter

Cite this chapter

Ramsay, A.J., Hogan, S.P., Foster, P.S., Xiong, Y. (2000). Cytokine gene therapy of allergic airways inflammation. In: Evans, C.H., Robbins, P.D. (eds) Gene Therapy in Inflammatory Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8478-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8478-5_5

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9584-2

  • Online ISBN: 978-3-0348-8478-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics